NO20003431L - Nye metalloproteaseinhibitorer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye metalloproteaseinhibitorer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO20003431L
NO20003431L NO20003431A NO20003431A NO20003431L NO 20003431 L NO20003431 L NO 20003431L NO 20003431 A NO20003431 A NO 20003431A NO 20003431 A NO20003431 A NO 20003431A NO 20003431 L NO20003431 L NO 20003431L
Authority
NO
Norway
Prior art keywords
group
preparation
methods
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO20003431A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003431D0 (no
Inventor
Guillaume De Nanteuil
Alain Benoist
Jacqueline Bonnet
Massimo Sabatini
Ghanem Atassi
Alain Pierre
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20003431D0 publication Critical patent/NO20003431D0/no
Publication of NO20003431L publication Critical patent/NO20003431L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
NO20003431A 1999-07-01 2000-06-30 Nye metalloproteaseinhibitorer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem NO20003431L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908448A FR2795730B1 (fr) 1999-07-01 1999-07-01 Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO20003431D0 NO20003431D0 (no) 2000-06-30
NO20003431L true NO20003431L (no) 2001-01-02

Family

ID=9547562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003431A NO20003431L (no) 1999-07-01 2000-06-30 Nye metalloproteaseinhibitorer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Country Status (21)

Country Link
US (1) US6339092B1 (de)
EP (1) EP1065209B1 (de)
JP (1) JP3330583B2 (de)
KR (1) KR100472521B1 (de)
CN (1) CN1147492C (de)
AT (1) ATE239021T1 (de)
AU (1) AU770168B2 (de)
BR (1) BR0002265A (de)
CA (1) CA2313302C (de)
DE (1) DE60002395T2 (de)
DK (1) DK1065209T3 (de)
EA (1) EA002527B1 (de)
ES (1) ES2198262T3 (de)
FR (1) FR2795730B1 (de)
HU (1) HUP0002554A3 (de)
NO (1) NO20003431L (de)
NZ (1) NZ505522A (de)
PL (1) PL341134A1 (de)
PT (1) PT1065209E (de)
SI (1) SI1065209T1 (de)
ZA (1) ZA200003310B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770647B2 (en) * 2001-08-17 2004-08-03 Bristol-Myers Squibb Pharma Company Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
DE102005002500A1 (de) * 2005-01-19 2006-07-27 Sanofi-Aventis Deutschland Gmbh Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen
BRPI0821315A2 (pt) * 2007-12-21 2019-09-24 Wyeth Llc compostos benzimidazol
KR100962022B1 (ko) 2010-01-12 2010-06-08 (주) 유니크코리아엔아이 정전용량형 압력센서 및 그 제조방법
JP6280573B2 (ja) * 2013-03-14 2018-02-14 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ ブロモドメイン阻害薬としてのフロピリジン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2748026B1 (fr) * 1996-04-26 1998-06-05 Adir Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE19719817A1 (de) * 1997-05-13 1998-11-19 Hoechst Ag Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
WO1999006410A1 (en) * 1997-08-04 1999-02-11 Amgen Inc. Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors

Also Published As

Publication number Publication date
HUP0002554A2 (hu) 2002-04-29
CA2313302C (fr) 2004-06-15
EA200000598A1 (ru) 2001-02-26
ZA200003310B (en) 2001-01-25
BR0002265A (pt) 2001-03-13
PL341134A1 (en) 2001-01-02
HK1034968A1 (en) 2001-11-09
HU0002554D0 (en) 2000-08-28
CA2313302A1 (fr) 2001-01-01
AU770168B2 (en) 2004-02-12
CN1147492C (zh) 2004-04-28
DE60002395D1 (de) 2003-06-05
NZ505522A (en) 2001-12-21
FR2795730A1 (fr) 2001-01-05
ATE239021T1 (de) 2003-05-15
EA002527B1 (ru) 2002-06-27
NO20003431D0 (no) 2000-06-30
JP2001039983A (ja) 2001-02-13
DK1065209T3 (da) 2003-08-25
AU4378400A (en) 2001-01-04
PT1065209E (pt) 2003-08-29
US6339092B1 (en) 2002-01-15
HUP0002554A3 (en) 2002-12-28
CN1290703A (zh) 2001-04-11
FR2795730B1 (fr) 2001-08-31
EP1065209A1 (de) 2001-01-03
SI1065209T1 (en) 2003-08-31
DE60002395T2 (de) 2004-04-08
KR20010039689A (ko) 2001-05-15
KR100472521B1 (ko) 2005-03-08
EP1065209B1 (de) 2003-05-02
JP3330583B2 (ja) 2002-09-30
ES2198262T3 (es) 2004-02-01

Similar Documents

Publication Publication Date Title
ES2190396T3 (es) Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR034268A1 (es) Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion
NO20076006L (no) Acetylenderivater
IL150650A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
NO20005715L (no) Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20065456L (no) Substituerte morfolinforbindelser for behandling av sykdommer i sentralnervesystemet
NO20073101L (no) Nye pyridinforbindelser
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
NO983493L (no) Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
NO20023251L (no) Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
AR018632A1 (es) Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion.
HUP0402033A2 (hu) 2-Amino-4-piridil-metil-tiazolin-származékok alkalmazása az indukálható NO-szintetáz inhibitoraként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO992731L (no) Nye substituerte tetrahydropyridinforbindelser, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger derav
NO20041761L (no) Nye hydroksyalkylindolokarbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
DK0514942T3 (da) Hidtil ukendte benzopyranderivater og fremgangsmåder til fremstilling deraf
NO20055167L (no) Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
EA200000598A1 (ru) Новые ингибиторы металлопротеазы, способ их получения и содержащие их фармацевтические композиции
NO20080677L (no) Ny 1H-indol-pyridinkarboksamid og 1H-indol-piperidinkarboksamidforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger som inneholder dem
NO20062307L (no) Spirofuropyridinarylderivater
NO20052598L (no) Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem.
NO20010801L (no) Nye 6-amino- eller 6-hydroazino-sulfonyl-3- kinolynylfosfonsyreforbindelse, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem
DE3689080D1 (de) Berbanderivate und ihre herstellung und pharmazeutische zubereitung.
NO20052330L (no) Nye substituerte [1,4]benzodioksino[2,3]isoindolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application